Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

ClinicalTrials.gov ID: NCT00321009

Public ClinicalTrials.gov record NCT00321009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Randomized Trial Comparing Enoxaparin to Warfarin for the Prevention of LV Thrombus Formation After Anterior Wall Myocardial Infarction: A 60 Patient Pilot Study

Study identification

NCT ID
NCT00321009
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Corewell Health East
Other
Enrollment
60 participants

Conditions and interventions

Interventions

  • Enoxaparin Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2000
Primary completion
Not listed
Completion
Mar 31, 2004
Last update posted
May 2, 2006

2000 – 2004

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
University of Colorado Health Sciences Center Denver Colorado 80262
William Beaumont Hospital Royal Oak Michigan 48073
St Joseph's Health Center Dept. of Cardiology Syracuse New York 13203
LaBauer Cardiovascular Research Foundation Greensboro North Carolina 27403
Doylestown Hospital Doylestown Pennsylvania 18901
Cardiovascular Associates Ltd. Virginia Beach Virginia 23454

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00321009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2006 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00321009 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →